scholarly journals Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study

2017 ◽  
Vol 1 (5) ◽  
pp. 394-405 ◽  
Author(s):  
Tomomi Kogiso ◽  
Hiroto Egawa ◽  
Satoshi Teramukai ◽  
Makiko Taniai ◽  
Etsuko Hashimoto ◽  
...  
2008 ◽  
Vol 14 (2) ◽  
pp. 245-251 ◽  
Author(s):  
Jacob Alexander ◽  
James D. Lord ◽  
Matthew M. Yeh ◽  
Carlos Cuevas ◽  
Ramasamy Bakthavatsalam ◽  
...  

2018 ◽  
Vol 53 (11) ◽  
pp. 2307-2311 ◽  
Author(s):  
Xiaolong Xie ◽  
Yang Wu ◽  
Qi Wang ◽  
Yiyang Zhao ◽  
Bo Xiang

2009 ◽  
Vol 15 (10) ◽  
pp. 1254-1261 ◽  
Author(s):  
Aldo J. Montano-Loza ◽  
Andrew L. Mason ◽  
Mang Ma ◽  
Ravin J. Bastiampillai ◽  
Vincent G. Bain ◽  
...  

2008 ◽  
Vol 14 (2) ◽  
pp. 138-143 ◽  
Author(s):  
Evangelos Cholongitas ◽  
Vibhakorn Shusang ◽  
George V. Papatheodoridis ◽  
Laura Marelli ◽  
Pinelopi Manousou ◽  
...  

2011 ◽  
pp. no-no ◽  
Author(s):  
Kuniko MAKIGAMI ◽  
Noriko OHTAKI ◽  
Norihisa ISHII ◽  
Tetsuko TAMASHIRO ◽  
Sadao YOSHIDA ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 3015 ◽  
Author(s):  
Barbara Lattanzi ◽  
Daria D’Ambrosio ◽  
Daniele Tavano ◽  
Demis Pitoni ◽  
Gianluca Mennini ◽  
...  

The development of nutritional and metabolic abnormalities represents an important burden in patients after liver transplantation (LT). Our study aimed at evaluating the incidence, time of onset, and risk factors for nutritional and metabolic abnormalities in patients after LT. The study was a single-center retrospective study. Consecutive patients undergoing elective LT from 2000 to 2016 were enrolled. The presence of at least two among arterial hypertension (AH), diabetes mellitus (DM), dyslipidemia, and obesity (BMI ≥ 30 Kg/m2) was utilized to define patients with the metabolic disorder (MD). Three hundred and fifteen patients were enrolled; the median age was 56 years (68% males). Non-alcoholic steatohepatitis (NASH) was the origin of liver disease in 10% of patients. During follow-up, 39% of patients developed AH, 18% DM, and 17% dyslipidemia. Metabolic disorders were observed in 32% of patients. The NASH etiology (OR: 6.2; CI 95% 0.5–3; p = 0.003) and a longer follow-up (OR: 1.2; CI 95% 0.004–0.02; p = 0.002) were associated with de novo MD. In conclusion, nutritional and metabolic disorders are a frequent complication after LT, being present in up to one-third of patients. The NASH etiology and a longer distance from LT are associated with de novo MD after LT.


Sign in / Sign up

Export Citation Format

Share Document